Anticancer compositions

C - Chemistry – Metallurgy – 08 – B

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C08B 37/00 (2006.01) A61K 31/715 (2006.01) A61K 31/716 (2006.01) A61P 35/00 (2006.01) A61P 37/04 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2469406

It is intended to provide anticancer compositions. It is newly found out that compositions containing a marine yeast-origin component having a .beta.1,3 glucan structure are efficacious IL-12 inducers which have never been known so far. It is also newly found out that the marine yeast-origin component having a .beta.1,3 glucan structure is expected as being capable of activating NK cells and NKT cells, when orally administered. Thus anticancer compositions can be successfully provided.

Cette invention a pour but de produire des compositions anticancéreuses. On a découvert récemment que des compositions contenant un composant provenant de levures marines ayant une structure .beta.1,3 glucan constituent des inducteurs efficaces d'IL-12 inconnus jusqu'ici. On a également découvert récemment que ce composant provenant de levures marines ayant une structure .beta.1,3 glucan est susceptible d'avoir la capacité d'activer les cellules NK et les cellules NKT, lorsqu'il est administré par voie orale. Des compositions anticancéreuse peuvent ainsi être produites avec succès.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anticancer compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anticancer compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anticancer compositions will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1840630

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.